Uses AI and automation to industrialize drug discovery and development for rare diseases and cancers.
About
Recursion Pharmaceuticals is a clinical-stage TechBio company that decodes biology using AI and automation to industrialize drug discovery. Their Recursion OS platform integrates biology, chemistry, and clinical development to accelerate the identification of novel drug targets and therapeutic candidates for diseases with high unmet needs, such as oncology and rare diseases.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals is a clinical-stage TechBio company that decodes biology using AI and automation to industrialize drug discovery. Their Recursion OS platform integrates biology, chemistry, and clinical development to accelerate the identification of novel drug targets and therapeutic candidates for diseases with high unmet needs, such as oncology and rare diseases.
How much funding has Recursion Pharmaceuticals raised?
Recursion Pharmaceuticals has raised a total of $623M in funding. The most recent round on record is Private Equity.
Where is Recursion Pharmaceuticals headquartered?
Recursion Pharmaceuticals is headquartered in Salt Lake City, United States.
When was Recursion Pharmaceuticals founded?
Recursion Pharmaceuticals was founded in 2013.
What industry does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals operates in Drug Discovery AI, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
Similar Startups